- Home
- NAGE vs GMRE Comparison
NAGE vs GMRE Comparison
Compare NAGE & GMRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NAGE | GMRE |
|---|---|---|
| Founded | 1999 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 507.6M | 473.0M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | NAGE | GMRE |
|---|---|---|
| Price | $5.97 | $33.82 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 2 |
| Target Price | $16.33 | ★ $40.50 |
| AVG Volume (30 Days) | ★ 788.1K | 71.8K |
| Earning Date | 03-03-2026 | 02-26-2026 |
| Dividend Yield | N/A | ★ 8.84% |
| EPS Growth | ★ 1093.81 | N/A |
| EPS | ★ 0.23 | N/A |
| Revenue | $124,709,000.00 | ★ $144,829,000.00 |
| Revenue This Year | $30.37 | $7.49 |
| Revenue Next Year | $20.36 | $3.18 |
| P/E Ratio | $25.67 | ★ N/A |
| Revenue Growth | ★ 36.04 | 6.04 |
| 52 Week Low | $5.25 | $29.05 |
| 52 Week High | $14.69 | $45.75 |
Technical Indicators
Market Signals| Indicator | NAGE | GMRE |
|---|---|---|
| Relative Strength Index (RSI) | 38.97 | 45.47 |
| Support Level | $5.98 | $33.80 |
| Resistance Level | $6.29 | $35.44 |
| Average True Range (ATR) | 0.24 | 0.73 |
| MACD | -0.02 | -0.22 |
| Stochastic Oscillator | 9.86 | 18.40 |
Price Performance
Historical ComparisonAbout NAGE Niagen Bioscience Inc.
Niagen Bioscience Inc is the leader in NAD+ (nicotinamide adenine dinucleotide) science and healthy-aging research. It is dedicated to advancing healthspan through precision science and innovative NAD+-boosting solutions. It is is clinically proven to increase NAD+ levels efficiently and effectively, and is the key ingredient powering our suite of Niagen brands.
About GMRE Global Medical REIT Inc.
Global Medical REIT Inc is engaged predominantly in the acquisition of purpose-built healthcare facilities and the leasing of those facilities to physician groups and regional and national healthcare systems. The company's principal business objective is to provide attractive, risk-adjusted returns to its stockholders through a combination of reliable dividends and long-term capital appreciation. Its healthcare facilities are located in secondary markets and suburbs of primary markets and are typically leased to single-tenants under triple-net leases.